These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 442280)

  • 21. Prospective study on the appearance of antibody-coated bacteria in patients with an indwelling urinary catheter.
    Kostiala AA; Nyrén P; Jokinen EJ; Runeberg L
    Nephron; 1982; 30(3):279-85. PubMed ID: 7048117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection.
    Kasanen A; Kaarsalo E; Hiltunen R; Soini V
    Ann Clin Res; 1974 Oct; 6(5):285-9. PubMed ID: 4475571
    [No Abstract]   [Full Text] [Related]  

  • 23. Formaldehyde generation from methenamine salts in spinal cord injury.
    Devenport JK; Swenson JR; Dukes GE; Sonsalla PK
    Arch Phys Med Rehabil; 1984 May; 65(5):257-9. PubMed ID: 6712452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethoprim and methenamine hippurate. A new theoretical combination for the treatment of urinary tract infections.
    Räisänen S; Ylitalo P; Toponen A; Seppänen J
    Scand J Infect Dis; 1985; 17(2):211-8. PubMed ID: 3895402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of urinary prophylaxis with methenamine in gynecologic surgery.
    Schiøtz HA; Guttu K
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):743-6. PubMed ID: 12174159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Types of urethral catheters for management of short-term voiding problems in hospitalised adults.
    Brosnahan J; Jull A; Tracy C
    Cochrane Database Syst Rev; 2004; (1):CD004013. PubMed ID: 14974052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
    Gow JG
    Practitioner; 1974 Jul; 213(1273):97-101. PubMed ID: 4280569
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention and treatment of catheter-associated urinary tract infections.
    Macfarlane DE
    J Infect; 1985 Mar; 10(2):96-106. PubMed ID: 3891871
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing catheter-related bacteriuria: should we? Can we? How?
    Saint S; Lipsky BA
    Arch Intern Med; 1999 Apr; 159(8):800-8. PubMed ID: 10219925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methamine hippurate--an old antiseptic in a new formula].
    Wallerström BG
    Lakartidningen; 1972 Dec; 69(50):5870-3. PubMed ID: 4650469
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term prophylaxis with methenamine hippurate in girls with recurrent urinary tract infections.
    Petersen S
    Acta Paediatr Scand; 1978 Sep; 67(5):597-9. PubMed ID: 358737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methenamine hippurate for preventing urinary tract infections.
    Lee B; Bhuta T; Craig J; Simpson J
    Cochrane Database Syst Rev; 2002; (1):CD003265. PubMed ID: 11869659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of indwelling catheters.
    Brocklehurst JC; Brocklehurst S
    Br J Urol; 1978 Apr; 50(2):102-5. PubMed ID: 38879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hexamethylene-tetramine hippurate in the treatment of urinary infections].
    Casselman J
    Acta Urol Belg; 1966 Jul; 34(3):354-8. PubMed ID: 5915552
    [No Abstract]   [Full Text] [Related]  

  • 36. The prolonged use of methenamine hippurate in the treatment of chronic urinary tract infection.
    Gerstein AR; Okun R; Gonick HC; Wilner HI; Kleeman CR; Maxwell MH
    J Urol; 1968 Dec; 100(6):767-71. PubMed ID: 5696669
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection.
    Vainrub B; Musher DM
    Antimicrob Agents Chemother; 1977 Nov; 12(5):625-9. PubMed ID: 921259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of ascorbic acid, hippuric acid, and methenamine (urinary formaldehyde) on the copper-reduction glucose test in geriatric patients.
    Nahata MC; McLeod DC
    J Am Geriatr Soc; 1980 May; 28(5):230-3. PubMed ID: 7365188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary catheters.
    Steward DK; Wood GL; Cohen RL; Smith JW; Mackowiak PA
    Am J Infect Control; 1985 Aug; 13(4):154-60. PubMed ID: 3850728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy reviews: methenamine mandelate and methenamine hippurate.
    Gleckman R; Alvarez S; Joubert DW; Matthews SJ
    Am J Hosp Pharm; 1979 Nov; 36(11):1509-12. PubMed ID: 391033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.